These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28294133)

  • 1. The GABA
    Augier E; Dulman RS; Damadzic R; Pilling A; Hamilton JP; Heilig M
    Neuropsychopharmacology; 2017 Aug; 42(9):1789-1799. PubMed ID: 28294133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking.
    Schank JR; Nelson BS; Damadzic R; Tapocik JD; Yao M; King CE; Rowe KE; Cheng K; Rice KC; Heilig M
    Neuropharmacology; 2015 Dec; 99():106-14. PubMed ID: 26188146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and side effects of baclofen and the novel GABA
    Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
    Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.
    Hwa LS; Kalinichev M; Haddouk H; Poli S; Miczek KA
    Psychopharmacology (Berl); 2014 Jan; 231(2):333-43. PubMed ID: 23975038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats.
    Augier E; Dulman RS; Rauffenbart C; Augier G; Cross AJ; Heilig M
    Neuropsychopharmacology; 2016 Nov; 41(12):2932-2940. PubMed ID: 27339394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The galanin receptor-3 antagonist, SNAP 37889, inhibits cue-induced reinstatement of alcohol-seeking and increases c-Fos expression in the nucleus accumbens shell of alcohol-preferring rats.
    Wilson KE; Limburg S; Duggan MK; Lawther AJ; Williams SJ; Lawrence AJ; Hale MW; Djouma E
    J Psychopharmacol; 2018 Aug; 32(8):911-921. PubMed ID: 29926762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABA
    Kalinichev M; Girard F; Haddouk H; Rouillier M; Riguet E; Royer-Urios I; Mutel V; Lütjens R; Poli S
    Neuropharmacology; 2017 Mar; 114():34-47. PubMed ID: 27889489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressing effect of CMPPE, a new positive allosteric modulator of the GABA
    Maccioni P; Fara F; Lorrai I; Acciaro C; Mugnaini C; Corelli F; Colombo G
    Alcohol; 2019 Mar; 75():79-87. PubMed ID: 30468987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GABA(B) receptor agents on cocaine priming, discrete contextual cue and food induced relapses.
    Filip M; Frankowska M
    Eur J Pharmacol; 2007 Oct; 571(2-3):166-73. PubMed ID: 17610868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
    Augier E
    Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific reduction of alcohol's motivational properties by the positive allosteric modulator of the GABAB receptor, GS39783--comparison with the effect of the GABAB receptor direct agonist, baclofen.
    Maccioni P; Fantini N; Froestl W; Carai MA; Gessa GL; Colombo G
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1558-64. PubMed ID: 18616673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of GABA
    Gawlińska K; Jastrzębska J; Gamberini S; Gawliński D; Pieniążek R; Suder A; Wydra K; Frankowska M
    Eur J Pharmacol; 2020 Sep; 883():173324. PubMed ID: 32621910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the Alpha-1 Antagonist Prazosin on KOR Agonist-Induced Reinstatement of Alcohol Seeking.
    Funk D; Coen K; Tamadon S; Lê AD
    Int J Neuropsychopharmacol; 2019 Nov; 22(11):724-734. PubMed ID: 31556948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KK-92A, a novel GABA
    Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
    Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional inactivation of the orbitofrontal cortex disrupts context-induced reinstatement of alcohol seeking in rats.
    Bianchi PC; Carneiro de Oliveira PE; Palombo P; Leão RM; Cogo-Moreira H; Planeta CDS; Cruz FC
    Drug Alcohol Depend; 2018 May; 186():102-112. PubMed ID: 29567624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA
    de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER
    Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GABA
    Haile CN; Carper BA; Nolen TL; Kosten TA
    Psychopharmacology (Berl); 2021 Sep; 238(9):2587-2600. PubMed ID: 34228136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of DA-Phen, a dopamine-aminoacidic conjugate, on alcohol intake and forced abstinence.
    Sutera FM; De Caro V; Cannizzaro C; Giannola LI; Lavanco G; Plescia F
    Behav Brain Res; 2016 Sep; 310():109-18. PubMed ID: 27155501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of GABA
    Maccioni P; Colombo G
    CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders.
    Domi E; Barbier E; Augier E; Augier G; Gehlert D; Barchiesi R; Thorsell A; Holm L; Heilig M
    Neuropsychopharmacology; 2018 Aug; 43(9):1805-1812. PubMed ID: 29463912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.